About Cochlin
Cochlin (COCH) is a protein
from Homo sapiens identified by UniProt accession
O43405, 550 residues long.
MolForge cross-references it against 0 known binders and
116 disease associations.
Target properties
| Protein name | Cochlin |
| UniProt accession | O43405 |
| Gene | COCH |
| Organism | Homo sapiens |
| Length | 550 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (116)
Diseases linked to this target (Open Targets).
- deafness · score 0.67
- autosomal dominant nonsyndromic hearing loss · score 0.65
- hearing loss, autosomal recessive 110 · score 0.62
- nonsyndromic genetic hearing loss · score 0.49
- Rare genetic deafness · score 0.45
- cortical thickness · score 0.41
- cortical surface area measurement · score 0.37
- blood protein measurement · score 0.36
- Hearing impairment · score 0.35
- Sensorineural hearing impairment · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43405-F1 | alphafold | PREDICTED | 85.43 | — |
Amino-acid sequence (550 residues)
MSAAWIPALG LGVCLLLLPG PAGSEGAAPI AITCFTRGLD IRKEKADVLC PGGCPLEEFS VYGNIVYASV SSICGAAVHR GVISNSGGPV RVYSLPGREN YSSVDANGIQ SQMLSRWSAS FTVTKGKSST QEATGQAVST AHPPTGKRLK KTPEKKTGNK DCKADIAFLI DGSFNIGQRR FNLQKNFVGK VALMLGIGTE GPHVGLVQAS EHPKIEFYLK NFTSAKDVLF AIKEVGFRGG NSNTGKALKH TAQKFFTVDA GVRKGIPKVV VVFIDGWPSD DIEEAGIVAR EFGVNVFIVS VAKPIPEELG MVQDVTFVDK AVCRNNGFFS YHMPNWFGTT KYVKPLVQKL CTHEQMMCSK TCYNSVNIAF LIDGSSSVGD SNFRLMLEFV SNIAKTFEIS DIGAKIAAVQ FTYDQRTEFS FTDYSTKENV LAVIRNIRYM SGGTATGDAI SFTVRNVFGP IRESPNKNFL VIVTDGQSYD DVQGPAAAAH DAGITIFSVG VAWAPLDDLK DMASKPKESH AFFTREFTGL EPIVSDVIRG ICRDFLESQQ
Explore Cochlin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets